Investor insights
Countries invested in
Sectors invested in
Funding rounds participated in
$44M sweet spot round size
Most of their 18 investments are in rounds between $20M and $93M
Investor type
Basic info
Industry
Sectors
Date founded
2003
Investments made
Kriya Therapeutics raised $270M on May 16, 2022
Investors: Narya, Transhuman Capital, Dexcel Pharma, Patient Square Capital, Foresite Capital, JDRF T1D Fund and QVT Financial LLP
Kriya Therapeutics raised $100M on July 14, 2021
Investors: Narya, Transhuman Capital, Dexcel Pharma, Foresite Capital, Woodline Partners LP, Patient Square Capital, JDRF T1D Fund and QVT Financial LLP
Kriya Therapeutics raised $81M on May 12, 2020
Investors: Transhuman Capital, Narya, Sahsen Ventures, LLC, Foresite Capital, Dexcel Pharma, Amplo, JDRF T1D Fund and QVT Financial LLP
Roivant Sciences raised $200M on November 13, 2018
Investors: Founders Fund, Dexcel Pharma, -, RTW Investments, LP, SoftBank Investment Advisers, Viking Global Investors and QVT Financial LLP
AveXis, Inc. raised $65M on September 8, 2015
Investors: Venrock, T. Rowe Price, RA Capital Management, L.P., Foresite Capital, RTW Investments, LP and QVT Financial LLP
REGENXBIO Inc. raised $71M on May 20, 2015
Investors: Sectoral Asset Management, Jennison Associates LLC, RTW Investments, LP, Perceptive Advisors, F-Prime Capital Partners, Venrock, Vivo Capital and QVT Financial LLP
Palatin Technologies raised $20M on December 24, 2014
Investors: QVT Financial LLP
Adaptimmune Ltd raised $104M on September 25, 2014
Investors: Merlin Nexus, Wellington Management, OrbiMed Advisors, venBio Partners, Ridgeback Capital Management LLC, Novo Holdings, University of Oxford and QVT Financial LLP
Flex Pharma raised $40M on September 8, 2014
Investors: City Hill Ventures, Correlation Ventures, Jennison Associates LLC, Spark Capital, Longwood Fund, Lightstone Ventures and QVT Financial LLP
Roivant Sciences raised $93M on May 1, 2014
Investors: Sahsen Ventures, LLC, Dexcel Pharma and QVT Financial LLP